Patients settle with Indiana cardiology providers for $66.5M over malpractice claims

Hundreds of patients accusing cardiologists in Munster, Indiana, of malpractice have reached a settlement of $66.5 million. The development comes at the end of a lengthy legal battle that included numerous lawsuits and made national headlines.

Cardiologist Arvind Gandhi, MD—who retired in 2014 after several medical malpractice lawsuits had already been filed—and his practice, Cardiology Associates of Northwest Indiana, were at the center of these lawsuits. Patients accused Gandhi, and some of his cardiologist colleagues, of recommending unnecessary medical procedures.

Two law firms representing the patients, Theodoros & Rooth and Cohen & Malad, LLP, issued a statement highlighting the settlement.

“The claims related to alleged unnecessary cardiac procedures and device implantations,” according to the statement. “The settling defendants deny that they had engaged in any negligent or otherwise improper conduct and deny any liability relative to the claims.”

The exact terms of the settlement remain confidential.

In 2015, the ongoing situation in Munster was the subject of an in-depth feature in the New York Times. The article included interviews with patients, former colleagues of Gandhi’s, policy experts and esteemed cardiologist Steven Nissen, MD, a former president of the American College of Cardiology.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.